Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
The Journal of Nutrition, Health & Aging|January 31, 2018
Mini Nutritional Assessment Short-Form (MNA-SF) Predicts Institutionalisation in an Intermediate Post-Acute Care SettingK Folven, E Biringer, J F AbrahamsenStrahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 1, 1990
Long-term morbidity after curative radiotherapy for carcinoma of the bladder. A retrospective studyJ F Abrahamsen, S D FossåTransfusion|November 29, 2001
Peripheral blood progenitor cell grafts contain high levels of platelet-secreted mediatorsB Foss, J F Abrahamsen, Ø BruserudThe Journal of Infusional Chemotherapy|January 1, 1995
Current concepts for chronochemotherapy of cancerO D Laerum, R Smaaland, J F AbrahamsenCytotherapy|September 9, 2005
Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kgJ F Abrahamsen, T Wentzel-Larsen, O BruserudJournal of Hematotherapy & Stem Cell Research|July 15, 2003
No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxideA M Bakken, O Bruserud, J F AbrahamsenIn Vivo (Athens, Greece)|November 1, 1995
Circadian cell kinetics in humans. Aspects related to cancer chemotherapyR Smaaland, O D Laerum, J F AbrahamsenEuropean Journal of Haematology|March 1, 1996
Flow cytometric measurement of DNA S-phase in human bone marrow cells: correcting for peripheral blood contaminationJ F Abrahamsen, R Smaaland, R Skjaerven, et al.European Journal of Haematology|April 1, 1993
Circadian variation in serum cortisol and circulating neutrophils are markers for circadian variation of bone marrow proliferation in cancer patientsJ F Abrahamsen, R Smaaland, S Sandberg, et al.Transfusion|January 22, 2005
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cellsJ F Abrahamsen, S Stamnesfet, K Liseth, et al.Pageof 3